Serological Markers and HLA-DQ2 Haplotype Among First-degree Relatives of Celiac Patients. Catalonian Coeliac Disease Study Group
Overview
Affiliations
Serologic markers, HLA-DQ2 haplotype, and clinical features suggestive of celiac disease were studied to assess their diagnostic value in a multicentric study to detect celiac disease in 675 first-degree relatives of 227 celiac probands. Serum IgA-class anti-endomysium and IgA-class anti-gliadin antibodies were positive in 5.8% and 1.9% of relatives, respectively. HLA-DQ2 haplotype was present in 64% of relatives, and the overall rate of celiac disease diagnosed by intestinal biopsy was 5.5%. The frequency of HLA-DQ2 in the celiac patients and controls was 93% and 18%, respectively. The most frequent clinical features--diarrhea, anemia, food intolerance, and growth retardation--were not present in one third of the celiac disease relatives. We conclude that the assessment of IgA-class anti-endomysium antibodies alone seems a reasonable approach for screening celiac disease in relatives and cannot be replaced by an accurate clinical anamnesis. HLA-DQ2 haplotype may identify the population with a high genetic susceptibility to celiac disease.
Capittini C, De Silvestri A, Rebuffi C, Tinelli C, Poddighe D Medicina (Kaunas). 2019; 55(5).
PMID: 31121940 PMC: 6571594. DOI: 10.3390/medicina55050190.
Towards an individual screening strategy for first-degree relatives of celiac patients.
Wessels M, de Rooij N, Roovers L, Verhage J, de Vries W, Mearin M Eur J Pediatr. 2018; 177(11):1585-1592.
PMID: 29974211 DOI: 10.1007/s00431-018-3199-6.
Singh P, Arora S, Lal S, Strand T, Makharia G Am J Gastroenterol. 2015; 110(11):1539-48.
PMID: 26416192 DOI: 10.1038/ajg.2015.296.
Clinical utility of celiac disease-associated HLA testing.
Pallav K, Kabbani T, Tariq S, Vanga R, Kelly C, Leffler D Dig Dis Sci. 2014; 59(9):2199-206.
PMID: 24705698 PMC: 4149591. DOI: 10.1007/s10620-014-3143-1.
Celiac disease: prevalence, diagnosis, pathogenesis and treatment.
Gujral N, Freeman H, Thomson A World J Gastroenterol. 2012; 18(42):6036-59.
PMID: 23155333 PMC: 3496881. DOI: 10.3748/wjg.v18.i42.6036.